Activity of N-(2-phenylethyl)-N-n-propyl-2-3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands

F. Claudi; M. Cardellini; A. D. Stefano; G. Giorgioni; F. Cantalamessa; F. Reno; W. Balduini

Activity of N-(2-phenylethyl)-N-n-propyl-2-3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands

F. Claudi, M. Cardellini, A. D. Stefano, G. Giorgioni, F. Cantalamessa, F. Reno, W. Balduini

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	115-125
Numero di pagine	11
Rivista	Drug Design and Discovery
Volume	11
Numero di pubblicazione	2
Stato di pubblicazione	Pubblicato - 1994
Pubblicato esternamente	Sì

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{f37a47f3c4894bd88b172bdad0d733a1,

title = "Activity of N-(2-phenylethyl)-N-n-propyl-2-3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands",

keywords = "Behavioural tests, Dopamine D and D receptor binding assays, N-n-propyl-N-(2-phenylethyl)-2-(3-hydroxyphenyl)ethylamine derivatives, Synthesis",

author = "F. Claudi and M. Cardellini and Stefano, {A. D.} and G. Giorgioni and F. Cantalamessa and F. Reno and W. Balduini",

year = "1994",

language = "English",

volume = "11",

pages = "115--125",

journal = "Drug Design and Discovery",

issn = "1055-9612",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Activity of N-(2-phenylethyl)-N-n-propyl-2-3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands

AU - Claudi, F.

AU - Cardellini, M.

AU - Stefano, A. D.

AU - Giorgioni, G.

AU - Cantalamessa, F.

AU - Reno, F.

AU - Balduini, W.

PY - 1994

Y1 - 1994

KW - Behavioural tests

KW - Dopamine D and D receptor binding assays

KW - N-n-propyl-N-(2-phenylethyl)-2-(3-hydroxyphenyl)ethylamine derivatives

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=0028219348&partnerID=8YFLogxK

M3 - Article

SN - 1055-9612

VL - 11

SP - 115

EP - 125

JO - Drug Design and Discovery

JF - Drug Design and Discovery

IS - 2

ER -